Managers / Q1 2026
PINCUS CAPITAL MANAGEMENT, LP
CIK 0002109652 · 126 EAST 56TH STREET, SUITE 810, NEW YORK, NY, 10022 · 646-571-1730
Summary
Pincus Capital Management, LP reported $144M in U.S.-listed holdings across 50 positions for Q1 2026.
The portfolio is heavily concentrated: PG alone accounts for 23.8% of reported value.
Compared with Q4 2025, the fund opened 1 new position and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 87.1% · $125M
- ETP · 11.9% · $17M
- Other · 0.6% · $916,708
- ADR · 0.4% · $615,069
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| JPMJPMORGAN CHASE & CO | NEW | +792 | 792 | +$232,975 | $232,975 |
| NOWSERVICENOW INC | SOLD OUT | −1.5K | 0 | −$231,317 | $0 |
| SPDR SERIES TRUST | SOLD OUT | −1.1K | 0 | −$215,211 | $0 |
| NVDANVIDIA CORPORATION | ADDED | +1.9K | 10.9K | +$224,075 | $2M |
| BSXBOSTON SCIENTIFIC CORP | TRIMMED | −828 | 3.7K | −$198,005 | $229,163 |
| ORCLORACLE CORP | TRIMMED | −353 | 2.2K | −$174,776 | $326,143 |
| EATON CORP PLC | TRIMMED | −183 | 2.6K | +$42,080 | $916,708 |
| TSMTAIWAN SEMICONDUCTOR MANUFAC | TRIMMED | −127 | 1.8K | +$23,395 | $615,069 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.